Additionally, high levels of RHBDD1 and RHBDF2 are correlated to poor prognosis of LGG, whereas RHBDD2 and PARL are markedly correlated to ACC disease progression. This evidence concerns the gene RHBDD2 and adrenal cortex carcinoma.